Clinical research organisation (CRO) Icon has begun the integration of Medidata Clinical Data Studio into its clinical ...

The global Central Lab Services Market, valued at US$5.64 billion in 2024, is forecasted to grow at a robust CAGR of 6.5%, ...

The global clinical trials market has emerged as a vital cornerstone of the healthcare sector, driven by an ever-increasing ...

For example, developing a drug nowadays takes eight to ten years and costs over $2bn, yet less than 10% of clinical ...

ICON Public Limited (NASDAQ:ICLR – Get Free Report) has been assigned a consensus rating of “Moderate Buy” from the fifteen ...

Fintel reports that on March 21, 2025, Goldman Sachs downgraded their outlook for ICON Public Limited (NasdaqGS:ICLR) from ...

The Goldman Sachs Group lowered shares of ICON Public (NASDAQ:ICLR – Free Report) from a buy rating to a neutral rating in a ...

ICON Public Limited Company ... stages of the clinical development process from compound selection to Phase I-IV clinical studies. It also provides clinical development services, including ...

The global Clinical Trial Services Market, valued at US$60.76 billion in 2024, is forecasted to grow at a robust CAGR of 8.9%, reaching US$66.59 ...

Arun Shourie’s new work is a clinical investigation of Savarkar’s writings to sift myth and facts ...